Scantox at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Scantox takes part in 2 sessions at ACT 2026 in San Antonio, and exhibits at Booth 614. Its program centres on genetic toxicology. It covers how to follow up genotoxicity signals from in vitro tests with animal studies, from choosing endpoints to analysing the data, and how error-corrected DNA sequencing (DuplexSeq) supports genomic safety assessment.

OrganizationACT 2026 Attendance
Scantox
Lille Skensved, Denmark
◆Platinum Supporter
scantox.com
Contract research organizations (CROs)Platinum Supporter
Danish preclinical CRO running GLP general, genetic and reproductive toxicology, plus discovery, bioanalysis and pharmaceutical analysis.
Booth
Exhibiting at Booth 614
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm
Talk
Sun Nov 15
3:00pm–3:30pm
Part of Navigating Genetic Toxicology through Drug Development: Interface of Practice, Strategy, and Regulatory Principles (CE7)
In Vivo Genetic Toxicology Testing Strategies to Follow Up In Vitro Hazards: Endpoint Selection, Study Design, Interpretation, and Data Analysis (CE7-4)
Genetic toxicology
Talk
Mon Nov 16
12:00pm–12:55pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Scantox

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction